US$ 26.33
glp-1 agonist cardiovascular outcomes and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 receptor agonist versus DPP-4
Description
Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature

Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas

Platelets, fragments of megakaryocytes, contain abundant information related to the central nervous system

Res Synth Methods 9(1):41

Multiple cost-reduction methods can address these financial barriers effectively
